VYSIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 07 Mar 2025)
What this means for you
Registered since 13 Nov 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Nov 2028: the §8 & §9 renewal).
Record
- Serial number
- 86684397
- Registration number
- 5607387
- Mark type
- Word mark
- Filed
- 06 Jul 2015
- Published for opposition
- 28 Jun 2016
- Registered
- 13 Nov 2018
- Next maintenance filing
- §8 & §9 renewal, due by 13 Nov 2028 (grace period to 13 May 2029)
- Attorney of record
- Jordan Heinz
Goods and services
- Class 005 — Pharmaceuticals: Reagents for medical use; tissue pretreatment solutions, wash reagents, and buffers for medical use; binding reagents for medical use; hybridization buffers for medical use; hybridization reagents for medical use
Owner
- Abbott Molecular Inc., Des Plaines, IL, US
- Abbott Molecular Inc., Des Plaines, IL, US
- Abbott Molecular Inc., Des Plaines, IL, US
Prosecution history
- 07 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Nov 2024 — TEAS SECTION 8 & 15 RECEIVED
- 13 Nov 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 May 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 May 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 27 May 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 May 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Nov 2018 — REGISTERED-PRINCIPAL REGISTER
- 06 Oct 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Aug 2018 — USE AMENDMENT FILED
- 17 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL